Recombinant IL-6R (Tocilizumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits IL-6R (Tocilizumab Biosimilar)
- IL-6R (Tocilizumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp IL-6R (Tocilizumab Biosimilar) est non-conjugé
-
Application
- ELISA
- Fonction
- Tocilizumab Biosimilar - Anti-IL-6R mAb
- Attributs du produit
- Antibody Type: IgG1Kappa
- Classe de qualité
- Research Grade
- Isotype
- IgG1 kappa
-
anti-IL-6R (Tocilizumab Biosimilar) antibody
Reactivité: Humain ELISA, InhA Hôte: Lapin Monoclonal RhPM-1 unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- 4°C for short term, -20°C for long term
-
- Antigène
- IL-6R (Tocilizumab Biosimilar)
- Abstract
- IL-6R (Tocilizumab Biosimilar) Produits
- Synonymes
- anticorps CD126, anticorps IL-6R-1, anticorps IL-6RA, anticorps IL6Q, anticorps IL6RA, anticorps IL6RQ, anticorps gp80, anticorps interleukin 6 receptor, anticorps IL6R
- Classe de substances
- Biosimilar
- Sujet
-
Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. - Numéro CAS
- 375823-41-9
-
Vous êtes ici:
